Four notes:
1. Second quarter revenue was up 53.5 percent year-over-year.
2. Proprietary products made up 64.5 percent of sales in the second quarter, compared to 47 percent during the same period last year.
3. The company saw increased expenses in the second quarter as the company prepares to launch new products under FDA review.
4. CEO Trent Northcutt said, “Our second quarter was another improved quarter for Aurora, as the company continued to get back to pre-COVID-19 revenue levels. That said, while pandemic headwinds still persist, we continue to be highly focused on developing more proprietary products.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.